According to the Centers for Disease Control and Prevention (CDC), about 1 out of 10 people will have a seizure during their lifetime. Most of these seizures will be epileptic seizures, which are ...
Please provide your email address to receive an email when new articles are posted on . Monthly seizure frequency percentage reduction was 68.73% for the entire study cohort. For those followed up in ...
The Phase 2 open-label, multicenter study evaluated safety, tolerability and efficacy of BMB-101 in adults with drug-resistant Absence Seizures and DEE. A total of 24 patients were enrolled, exceeding ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Among those deemed “treatment sensitive,” 69.4% ...
Optogenetics employs a harmless virus to deliver light-sensitive genes to a particular set of neurons in the brain that can then be switched on and off with pulses of light. In a first, UC researchers ...
Add-on CBD treatment led to a reduction in seizure burden and improved nonseizure outcomes among patients with Lennox-Gastaut syndrome and Dravet syndrome. Add-on cannabidiol (CBD) treatment leads to ...
Emily Kalina describes it like it’s something out of a sci-fi movie: “It sounds really bizarre when I say it, but I download the data from my brain and I put it into a computer, and I send it off to ...
Scientists are unraveling the role of senescent cells in a common form of epilepsy, and it could point to new treatments.
"The gap between patient beliefs and available scientific evidence highlights a set of factors that confound cannabinoid research and therapy, including the naturalistic fallacy (the belief that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results